XT
ENZ

XTX Topco’s Enzo Biochem, Inc. ENZ Stock Holding History

XTX Topco’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-44,880
Closed -$30.4K – 3490
2025
Q2 		$30.4K Buy
44,880
+23,687
+112% +$7.65K ﹤0.01% 2105
2025
Q1 		$7.84K Buy
21,193
+5,285
+33% +$2.92K ﹤0.01% 2275
2024
Q4 		$11.4K Sell
15,908
-18,446
-54% -$19.1K ﹤0.01% 2134
2024
Q3 		$38.5K Buy
34,354
+6,092
+22% +$6.82K ﹤0.01% 1737
2024
Q2 		$30.8K Buy
28,262
+13,735
+95% +$15.5K ﹤0.01% 1567
2024
Q1 		$18.4K Buy
+14,527
New +$19.2K ﹤0.01% 1619
2021
Q3 		– Sell
-14,737
Closed -$47K – 1125
2021
Q2 		$47K Buy
+14,737
New +$46.3K 0.02% 730

XTX Topco's ENZ Position: Q3 2025 in Review

XTX Topco sold out of Enzo Biochem, Inc. (ENZ) in Q3 2025, closing a stake of 44,880 shares — an estimated $30.4K sold.

XTX Topco first reported a position in ENZ in Q2 2021 and held it in 7 quarters. The position peaked at $47K in Q2 2021. 0 funds tracked by Wall St. Rank hold ENZ as of Q3 2025.

  • XTX Topco reported no remaining Enzo Biochem, Inc. position as of Q3 2025 after selling out during the quarter.
  • XTX Topco sold 44,880 Enzo Biochem, Inc. shares in Q3 2025, an estimated $30.4K.
  • XTX Topco first reported a position in Enzo Biochem, Inc. in Q2 2021 and held it in 7 quarters.
  • XTX Topco's Enzo Biochem, Inc. position peaked at $47K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2025.

Based on XTX Topco's 13F filing for Q3 2025, filed 14 Nov 2025.